Oxygen therapy for children with Down Syndrome and sleep apnea
Official title: Randomized Control Trial of Oxygen Therapy in Children and Adolescents With Down Syndrome and Obstructive Sleep Apnea
Run by Brigham and Women's Hospital · NCT06043440 · Data updated 2026-11-12
This study is testing whether giving extra oxygen during sleep can help improve thinking skills and overall health in children with Down Syndrome who have sleep apnea.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 5 Years to 18 Years |
| Sex | All |
| Enrollment | 230 (estimated) |
| Sponsor | Brigham and Women's Hospital Academic / other |
| Locations | 7 sites (Los Angeles, California and 6 other locations) |
| Status | Recruiting |
| Started | October 24, 2023 |
| Main results expected | November 30, 2027 |
| Study ends | December 30, 2027 |
| Registry record updated | September 30, 2026 |
| Trial ID | NCT06043440 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 5 to 17.9 years with moderate to severe obstructive sleep apnea and a favorable response to oxygen therapy.
✕Probably not a fit
Patients who have clinically significant hypoxia or those who have already undergone adenotonsillectomy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effects of oxygen supplementation during sleep on cognitive function and other health outcomes in children with Down Syndrome who have moderate to severe Obstructive Sleep Apnea. It is a randomized, single-blind study lasting six months, where participants will undergo various assessments including polysomnography, neurocognitive testing, and echocardiography. The study will recruit children from sleep clinics, Down syndrome clinics, and local associations, focusing on those who have not responded to standard treatments like adenotonsillectomy.
Why it matters
Potential benefit: If successful, this study could enhance cognitive function and overall quality of life for children with Down Syndrome suffering from sleep apnea.
How similar studies have gone: Other studies have explored oxygen therapy in similar contexts, but this specific approach in children with Down Syndrome and sleep apnea is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Ages 5.0 to 17.9 years at the time of screening 2. Children with OSA and obstructive apnea hypopnea index (OAHI) ≥5/hour. 3. Absence of clinically significant hypoxia defined as oxygen saturation \<88% for 5 minutes or episodic desaturation to 60% as these levels would otherwise identify children eligible to routinely receive oxygen. 4. Favorable response to oxygen therapy (allowing randomization) will be defined as follows: 1. Oxygen saturation nadir \>92% and 2. Decrease in obstructive index \< 5 / hour or by \> 50% from screening PSG 3. Reaching an optimum oxygen flow which is defined as the flow that achieves the lowest level of AHI with maximum CO2 level less than 65 mmHg observed for 5 consecutive minutes and or an increase in CO2 by less than 15 points above baseline. The above criteria are observed while the patient spends a minimal of 30 minutes in the supine position and at least one cycle of rapid eye movement (REM) sleep. 4. Oxygen flow required does not exceed 3.0 LPM and does not exceed a FiO2 \> 40 %. 5. Willingness to comply with all study procedures and available for duration of study. 6. At baseline the participant attempts to perform the neuropsychological tests Exclusion Criteria: 1. Current CPAP use with documented compliance(\> 4 hrs/ night; \> 70% of nights). 2. Oxygen saturation \< 90% at rest during wakefulness. 3. Chronic daytime or nighttime use of supplemental oxygen. 4. Smoker in the child's bedroom. 5. Unrepaired congenital heart disease. 6. Moderate to severe pulmonary hypertension requiring treatment with oxygen and or pulmonary vasodilator. 7. Unable to participate in a PSG. 8. Individuals who develop alveolar hypoventilation with oxygen as previously defined. 9. Other severe chronic diseases determined by their provider as making them poor study candidates. 10. Enrolled or planning to enroll in another study that may conflict with protocol requirements or confound results in this trial. 11. Documented clinically significant untreated hypothyroidism 12. Children with adenotonsillar hypertrophy who are candidates for adenotonsillectomy and parents agree to the surgery.
Where it's running
-
Children's Hospital of Los Angeles
Los Angeles, California, United States Recruiting -
University of Michigan, Ann Arbor Hospital
Ann Arbor, Michigan, United States Recruiting -
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States Recruiting -
Rainbow Babies and Children's Hospital, Case Medical Center
Cleveland, Ohio, United States Recruiting -
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States Recruiting -
East Virginia Medical Center
Norfolk, Virginia, United States Recruiting
Show 1 more location
-
Seattle Children's Hospital
Seattle, Washington, United States Recruiting
Study contacts
- Principal investigator: Susan Redline — Brigham and Women's Hospital
- Study coordinator: Oltion Sina
- Email: osina@bwh.harvard.edu
- Phone: 8573407909
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating non-invasive ventilation for sleep apnea in children with Down syndrome
This study is trying to see if using a non-invasive breathing machine can help children with Down syndrome who have sleep apnea sleep better and improve their quality of life.
-
Using a special airway device to treat sleep apnea in children with weak muscles
This study is testing a special airway device to see if it can help children with weak muscles who have sleep apnea breathe better at night without needing surgery.
-
Personalized surgery for obstructive sleep apnea in children with Down syndrome
This study is testing a personalized surgery approach to treat obstructive sleep apnea in children with Down syndrome to see if it works better than standard surgery.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.